论文部分内容阅读
目的观察应用胺碘酮进行治疗心律失常患者的疗效情况。方法选取2015年12月~2016年2月我院收治的心律失常患者78例作为研究对象,按其临床治疗药物的不同归类分为对照组和观察组,各39例。对照组患者均服用心律平,而观察组患者均服用胺碘酮,对比两组患者的改善疗效。结果两组患者均接受7周的治疗,对照组的治疗总有效率为79.49%(31/39),而观察组的总有效率为97.44%(38/39),观察组明显优于对照组,差异有统计学意义(P<0.05)。结论胺碘酮属于一种具有强抗心律失常的药性作用,其应用的安全性高,疗效又十分可靠,与心律平药物相比,其更能有效改善心律失常患者,促进心功能恢复,值得在临床治疗心律失常患者时推广胺碘酮的应用范围。
Objective To observe the efficacy of amiodarone in the treatment of patients with arrhythmia. Methods 78 cases of arrhythmia admitted in our hospital from December 2015 to February 2016 were selected as the research object, divided into control group and observation group according to the different classification of clinical treatment drugs, 39 cases in each group. Patients in the control group were treated with amiodarone, while patients in the observation group were given amiodarone compared with those in the two groups. Results Both groups received 7 weeks of treatment, the total effective rate of the control group was 79.49% (31/39), while the observation group’s total effective rate was 97.44% (38/39), the observation group was significantly better than the control group , The difference was statistically significant (P <0.05). Conclusions Amiodarone belongs to a kind of pharmacological action with strong antiarrhythmic effect. It has high safety and reliable curative effect. It is more effective than arxamycin in improving arrhythmia patients and promoting cardiac function recovery Amiodarone in the clinical treatment of patients with the promotion of the scope of application.